Article citations

    Railan, D., Fivenson, D.P. and Wittenberg, G. (2000) Capillary Leak Syndrome in a Patient Treated with Interleukin 2 Fusion Toxin for Cutaneous T-Cell Lymphoma. Journal of the American Academy of Dermatology, 43, 323-324.
    http://dx.doi.org/10.1067/mjd.2000.106373

has been cited by the following article:

  • TITLE: The Current Opinions of Capillary Leak Syndrome
  • AUTHORS: Jun Su, Ying Zhang, Wei Hu
  • KEYWORDS: Capillary Leak Syndrome, Pathogenesis, Treatment, Continuous Blood Purification
  • JOURNAL NAME: Open Journal of Clinical Diagnostics DOI: 10.4236/ojcd.2015.51003 Mar 13, 2015
  • ABSTRACT: Capillary Leak Syndrome (CLS) in patients with severe course of disease is more and more common, and the clinical manifestations of CLS include systemic edema, hypoproteinemia, effective circulating blood volume reduction and hemoconcentration. The common pathogenies are sepsis, severe trauma, cardiopulmonary bypass and so on. Clinically, CLS is usually divided into leakage period and recovery period, with different pathophysiologic process, clinical manifestation and treatment in different period respectively. Although there are more treatments, they are not effective treatment measures. There have been so many studies about improvement of endothelial function, macromolecular colloid liquid applications, and continuous blood purification treatment. Systematic understanding of the pathological mechanism, clinical manifestations and staging, diagnosis and treatment of the CLS has a guiding value.